(Q39804868)

14 September 2017

title

Prevention of hepatitis E: another step forward (English)

1 reference

14 September 2017

1 reference

2

1 reference

14 September 2017

Amit Goel

1

1 reference

14 September 2017

publication date

1 January 2011

1 reference

14 September 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

Future Microbiology

1 reference

14 September 2017

volume

6

1 reference

14 September 2017

issue

1

1 reference

14 September 2017

page(s)

23-27

1 reference

Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.151

Hepatitis E virus and chronic hepatitis in organ-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.151

Persistent carriage of hepatitis E virus in patients with HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.151

Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.151

Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.151

Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.151

Epidemiology of hepatitis E: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.151

Acute hepatitis E in south-west France over a 5-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.151

Autochthonous hepatitis E in southwest England

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.151

In vitro infection and replication of hepatitis E virus in primary cynomolgus macaque hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.151

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.151

Preliminary evidence that a trpE-HEV fusion protein protects cynomolgus macaques against challenge with wild-type hepatitis E virus (HEV).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.151

Successful passive and active immunization of cynomolgus monkeys against hepatitis E

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.151

Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.151

Safety and efficacy of a recombinant hepatitis E vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.151

A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.151

21 January 2018

Identifiers

DOI

10.2217/FMB.10.151

1 reference

14 September 2017

1 reference